“antibody” Archives

in
Entry Author Date Location
Sanofi Wins FDA Nod for Combo Therapy in Multiple Myeloma 03/03/20 National
Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate 02/05/20 San Francisco
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease 02/28/19 San Diego
OncoResponse Buys Paganini Biopharma to Add Cancer Drug to Pipeline 11/08/17 Texas
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Chinese Pharma Licenses Two Drugs from UT Schools For $4.5M Upfront 06/23/17 Texas
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
Biomed Researchers at San Antonio’s UT Health Pitch for $25K Awards 11/17/16 Texas
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
Bioz, Using Machine Learning to Optimize Biology, Launches With $3M 07/20/16 San Francisco
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia 03/04/16 Texas
Antibody Maker AnaptysBio Joins IPO Queue With $86M In Its Sights 09/09/15 San Diego
West Coast Biotech Roundup: Regulus, Ardelyx, Juno, Sangamo & More 06/04/15 San Francisco
Bluebird Adds to CAR-T Arsenal With Five Prime Antibody Deal 05/26/15 Boston
With $35M Infusion, True North Moves Rare Disease Drug Into Clinic 04/07/15 San Francisco
Invenra Advancing Its Cell-Free Antibody Tech With $2M in New Cash 01/29/15 Wisconsin
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Verizon Buys CloudSwitch, Adimab Inks Biogen and Novo Nordisk Deals, EMD Millpore Buys Amnis, & More Boston-Area Deals News 08/31/11 Boston
Adimab Inks Collaboration Deals with Biogen Idec, Novo Nordisk 08/29/11 Boston
Excelimmune Nabs $10.5M Series B Deal 05/31/11 Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News 03/04/11 Boston
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News 12/03/10 Boston
Merck Ends AVEO Collaboration 09/30/10 Boston
Excelimmune Raises $1M 02/12/10 Boston
Life Science Leaders Converge in Newport, PubGet Gets Your Paper Faster, I-Therapeutix Eyes $15M Prize & More Boston-Area Life Sciences News 06/24/09 Boston
Page 1 of 1